Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration

Mayo Clinic

Status: Completed

Conditions: Hepatic Encephalopathy

Treatments: Other: Dieta mobile application

Study type: Interventional

Funder types: Other

Identifiers

NCT05526404

22-006646

Details and patient eligibility

About

This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ability to provide written, informed consent.
• Currently taking lactulose daily for prevention of hepatic encephalopathy.

Exclusion criteria

• Recent change in dosing of opioid medication.
• Previous Colorectal Surgery.
• Active diarrheal illness.
• Lack of smartphone or other smart device at home.

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Mobile application-based Bristol stool scale

Experimental group

Description:

Subjects with cirrhosis who are taking lactulose for the treatment of hepatic encephalopathy will download the Dieta mobile application on their mobile device and take a photo of each bowel movement using the Dieta application

Treatment:

Other: Dieta mobile application